Alamar Biosciences Secures Over $50 Million Funding and Strengthens Leadership Team#USA#Fremont#Alamar_Biosciences#Precision_Proteomics#Stephen_Williams
Alamar Biosciences Secures Over $50 Million Funding and Strengthens Leadership Team
Alamar Biosciences announces significant funding and a strengthened leadership team, marking a pivotal moment for advancements in precision proteomics.
third-news.com
January 12, 2026 at 4:55 PM
Alamar Biosciences Secures Over $50 Million Funding and Strengthens Leadership Team#USA#Fremont#Alamar_Biosciences#Precision_Proteomics#Stephen_Williams
Alamar Biosciences Completes Over-Subscribed Convertible Debt Financing and Expands Leadership Team#USA#Fremont#Alamar_Biosciences#Precision_Proteomics#Convertible_Financing
Alamar Biosciences Completes Over-Subscribed Convertible Debt Financing and Expands Leadership Team
Alamar Biosciences announces significant funding advancement and key leadership additions to enhance its precision proteomics capabilities.
third-news.com
January 12, 2026 at 1:32 PM
Alamar Biosciences Completes Over-Subscribed Convertible Debt Financing and Expands Leadership Team#USA#Fremont#Alamar_Biosciences#Precision_Proteomics#Convertible_Financing
Alamar Biosciences Achieves Oversubscribed Convertible Notes Financing and Expands Leadership Team#USA#Fremont#Alamar_Biosciences#Precision_Proteomics#Stephen_Williams
Alamar Biosciences Achieves Oversubscribed Convertible Notes Financing and Expands Leadership Team
Alamar Biosciences has completed a successful financing round, raising over $50 million and announced significant leadership expansions with industry veterans.
third-news.com
January 12, 2026 at 12:13 AM
Alamar Biosciences Achieves Oversubscribed Convertible Notes Financing and Expands Leadership Team#USA#Fremont#Alamar_Biosciences#Precision_Proteomics#Stephen_Williams
Alamar Biosciences Completes Oversubscribed Financing and Leadership Team Expansion#USA#Early_Detection#Fremont#Alamar_Biosciences#Precision_Proteomics
Alamar Biosciences Completes Oversubscribed Financing and Leadership Team Expansion
Alamar Biosciences has successfully closed an oversubscribed convertible note financing and announced significant leadership team expansions to support its growth.
third-news.com
January 12, 2026 at 12:02 AM
Alamar Biosciences Completes Oversubscribed Financing and Leadership Team Expansion#USA#Early_Detection#Fremont#Alamar_Biosciences#Precision_Proteomics
Alamar Biosciences Secures Oversubscribed Funding and Leadership Expansion#USA#Fremont#Alamar_Biosciences#T._Rowe_Price#Precision_Proteomics
Alamar Biosciences Secures Oversubscribed Funding and Leadership Expansion
Alamar Biosciences has successfully completed an oversubscribed funding round, introducing new leadership to enhance its precision proteomics platform and advance early disease detection.
third-news.com
January 11, 2026 at 9:17 PM
Alamar Biosciences Secures Oversubscribed Funding and Leadership Expansion#USA#Fremont#Alamar_Biosciences#T._Rowe_Price#Precision_Proteomics
Alamar Biosciences Secures Over $50 Million in Financing and Strengthens Leadership Team#USA#Fremont#Alamar_Biosciences#T._Rowe_Price#Precision_Proteomics
Alamar Biosciences Secures Over $50 Million in Financing and Strengthens Leadership Team
Alamar Biosciences announces the closure of an oversubscribed convertible note financing of over $50 million and strengthens its leadership team.
third-news.com
January 11, 2026 at 9:17 PM
Alamar Biosciences Secures Over $50 Million in Financing and Strengthens Leadership Team#USA#Fremont#Alamar_Biosciences#T._Rowe_Price#Precision_Proteomics
Alamar Biosciences Launches NULISAqpcr™ Custom Assay Development Kit to Propel Clinical Research#USA#Fremont#Alamar_Biosciences#NULISAqpcr™#Precision_Proteomics
Alamar Biosciences Launches NULISAqpcr™ Custom Assay Development Kit to Propel Clinical Research
Alamar Biosciences introduces the NULISAqpcr™ kit, enhancing biomarker analysis for clinical research and advancing precision proteomics.
third-news.com
February 25, 2025 at 8:04 PM
Alamar Biosciences Launches NULISAqpcr™ Custom Assay Development Kit to Propel Clinical Research#USA#Fremont#Alamar_Biosciences#NULISAqpcr™#Precision_Proteomics